Everest Organics informs about statement of investor complaints

06 Apr 2017 Evaluate

Everest Organics has informed about Statement of Investor Complaints during the quarter ended 31.03.2017 under regulation 13 (3) of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Everest Organics Share Price

437.10 -43.70 (-9.09%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×